This inventor holds 113 USPTO granted patents and 37 published patent applications, plus 15 CIPO patents and 26 EPO patents, primarily in Tissue Engineering (CPC class A61L27-24). Top assignees: Wake Forest University, Children's Medical Center Corporation, Massachusetts Institute of Technology. Active years: 1994-2026.
Inventors with similar research interests:
Location History:
- Wesson, MA (US) (1998)
- Newton, MA (US) (1994 - 2000)
- Weston, MA (US) (1996 - 2006)
- Winston Salem, MA (US) (2009 - 2010)
- Winston Salem, NC (US) (2008 - 2024)
Company Filing History:
71 out of 524 
37 out of 1,072 
4 out of 8,576 
Years Active: 1994-2026
Areas of Expertise:
Title: Anthony Atala: Pioneering Innovations in Biomedical Engineering
Introduction:
Anthony Atala, a renowned scientist and inventor based in Winston-Salem, NC, is widely recognized for his groundbreaking work in the field of biomedical engineering. With an impressive portfolio of 100 patents to his name, Atala has made significant contributions to the development of regenerative medicine and tissue engineering. This article explores some of his latest patents, his notable affiliations, and the collaborations with his esteemed colleagues.
Inventive Patents:
One of Atala's recent patents titled "Methods of producing in vitro liver constructs and uses thereof" showcases his pioneering work in creating artificial liver constructs. This patent outlines a cell composition that includes various types of liver cells, such as hepatocyte cells, Kupffer cells, hepatic stellate cells, sinusoidal endothelial cells, and cholangiocyte cells. This innovative approach holds immense potential for advancing liver tissue engineering and exploring new treatments for liver diseases.
Another notable patent attributed to Atala is "Oxygen-generating compositions for enhancing cell and tissue survival in vivo." This patent describes a method of treating hypoxic tissue, like wounds, by contacting a composition to the affected area. The composition consists of a biodegradable polymer and an inorganic peroxide incorporated into it. This technology addresses the crucial challenge of providing oxygen to oxygen-deprived tissues, thereby promoting tissue survival and regeneration.
Career and Affiliations:
Anthony Atala has held key positions at various prestigious institutions throughout his illustrious career. He is currently affiliated with Wake Forest University Health Sciences, a leading research institution renowned for its focus on regenerative medicine. Atala's dedication to advancing healthcare technologies is exemplified by his tenure as the Director of the Wake Forest Institute for Regenerative Medicine.
Collaborations and Contributions:
Working alongside talented colleagues, Atala has fostered numerous successful collaborations. Notably, his partnership with James J. Yoo, a prominent regenerative medicine expert, has resulted in several groundbreaking projects. Their combined expertise has led to transformative advancements in biofabrication, the development of artificial organs, and the application of stem cell technologies.
Atala has also collaborated with Sang Jin Lee, a respected researcher specializing in biomaterials and tissue engineering. Together, they have explored innovative approaches to tissue regeneration and transplantation, focusing on improving long-term outcomes and reducing the risks associated with these procedures.
Conclusion:
Anthony Atala's remarkable career, extensive patent portfolio, and collaborations with esteemed colleagues have cemented his position as a leading figure in the field of biomedical engineering. His innovative achievements in regenerative medicine and tissue engineering continue to push the boundaries of what is possible in healthcare. Through his visionary work, Atala offers hope for innovative solutions to some of the most pressing medical challenges of our time.